# Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

> **NCT00235872** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 309 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** adalimumab

## Key facts

- **NCT ID:** NCT00235872
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-07
- **Final completion:** —
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2011-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235872, "Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00235872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*